Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment
Mohammad Farhad, Annah S. Rolig, William L. Redmond
OncoImmunology (2018) Vol. 7, Iss. 6
Open Access | Times Cited: 175

Showing 26-50 of 175 citing articles:

Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer
Alyaa Dawoud, R.A. Youness, Heba Nafea, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
Yinghui Ren, Yongmei Qian, Qicheng Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Roles of galectin-3 in metabolic disorders and tumor cell metabolism
Yingshuang Li, Xiaotong Li, Lu‐Gang Yu, et al.
International Journal of Biological Macromolecules (2019) Vol. 142, pp. 463-473
Closed Access | Times Cited: 53
Chelate-soluble pectin fraction from papaya pulp interacts with galectin-3 and inhibits colon cancer cell proliferation
Samira Bernardino Ramos do Prado, Gustavo Ramalho Cardoso dos Santos, Paulo A.S. Mourão, et al.
International Journal of Biological Macromolecules (2018) Vol. 126, pp. 170-178
Closed Access | Times Cited: 52
Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
Daniel Compagno, Carolina Tiraboschi, José Daniel Garcia Garcia, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 750-750
Open Access | Times Cited: 47
Pectin-Tannic Acid Nano-Complexes Promote the Delivery and Bioactivity of Drugs in Pancreatic Cancer Cells
Sumeet S. Chauhan, Advait Shetty, Elham Hatami, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 285-285
Open Access | Times Cited: 45
Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity
Elizabeth R. Sturgill, Annah S. Rolig, Stefanie N. Linch, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 36
Zerumbone, a humulane sesquiterpene from Syringa pinnatifolia, attenuates cardiac fibrosis by inhibiting of the TGF-β1/Smad signaling pathway after myocardial infarction in mice
Junjun Li, Fuxing Ge, Shana Wuken, et al.
Phytomedicine (2022) Vol. 100, pp. 154078-154078
Closed Access | Times Cited: 24
Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions
Lara Gibellini, Rebecca Borella, Elena Santacroce, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3327-3327
Open Access | Times Cited: 16
Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
Joseph Mabbitt, Ian D. Holyer, James A. Roper, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma
Yusuke Matoba, Dominique T. Zarrella, Venkatesh Pooladanda, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 9, pp. 1463-1476
Open Access | Times Cited: 5
Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
Marta Nyakas, Elin Aamdal, Krag Jacobsen, et al.
Clinical & Experimental Immunology (2019) Vol. 197, Iss. 1, pp. 74-82
Open Access | Times Cited: 39
Galectin functions in cancer-associated inflammation and thrombosis
Linus Kruk, Attila Braun, Érika Cosset, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 12
The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host–Pathogen Interactions
Bojana Stojanović, Bojan Stojanović, Jelena Milovanović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9617-9617
Open Access | Times Cited: 12
Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases
Yibo Fan, Shumei Song, Yuan Li, et al.
Cancer Research (2023) Vol. 83, Iss. 22, pp. 3726-3738
Open Access | Times Cited: 12
Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth
Alberto Rivera-Ramos, Luis Cruz-Hernández, Rocío Talaverón, et al.
Cancer Letters (2024) Vol. 591, pp. 216879-216879
Open Access | Times Cited: 4
Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials
Samuel Dinerman, Yan Shu
International Journal of Translational Medicine (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
The clinical impact of galectin-8 in drug resistant breast cancer
Yi-Chung Chien, Jiayan Wu, Chun Pang, et al.
Journal of Cancer (2025) Vol. 16, Iss. 4, pp. 1296-1309
Open Access
Study of immunosenescence in the occurrence and immunotherapy of gastrointestinal malignancies
Daosong Dong, Yu Xue, Haoran Liu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Basic-Clinical Analysis of Parathyroid Cancer
Lucas Fuenzalida Mery, Sebastián Indo, Héctor R. Contreras, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 687-687
Open Access
Biosynthesis of pectin and its vital role in the bioavailability of phytochemicals associated with therapeutic properties
Rajesh Kumar, Devika Srivastava, Abhishek Verma, et al.
Pharmacological Research - Natural Products (2025), pp. 100214-100214
Closed Access
The role of immune checkpoints PD-1 and CTLA-4 in cardiovascular complications leading to heart failure
Song Huang, Yu Kang, Ting Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Galectin-3 modulates cellular infectivity and inflammatory response mediated by spike protein of SARS-CoV2
Yuviana J. Singh, Sudhakar Singh, Manpreet Kaur, et al.
International Journal of Biological Macromolecules (2025), pp. 143182-143182
Closed Access
Proteome-wide Identification of Glycosylation-dependent Interactors of Galectin-1 and Galectin-3 on Mesenchymal Retinal Pigment Epithelial (RPE) Cells
Jara Obermann, Claudia Priglinger, Juliane Merl‐Pham, et al.
Molecular & Cellular Proteomics (2017) Vol. 16, Iss. 8, pp. 1528-1546
Open Access | Times Cited: 38
LAG-3 and GAL-3 in Endometrial Carcinoma: Emerging Candidates for Immunotherapy
Lisa Aronson Friedman, Kari L. Ring, Anne M. Mills
International Journal of Gynecological Pathology (2019) Vol. 39, Iss. 3, pp. 203-212
Closed Access | Times Cited: 30

Scroll to top